RESMED INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $1.8b $2.1b $2.3b $2.6b $3.0b $3.2b $3.6b $4.2b $4.7b $5.1b
Cost of Revenue $772.2m $865.0m $978.0m $1.1b $1.2b $1.4b $1.6b $1.9b $2.0b $2.1b
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization $1.2b $1.3b $1.5b $1.8b $2.0b $2.1b
Gross Profit $1.1b $1.2b $1.4b $1.5b $1.7b $1.8b $2.0b $2.4b $2.7b $3.1b
Operating Expenses $637.5m $775.9m $820.3m $957.3m $908.1m $935.4m $1.0b $1.2b $1.3b $1.4b
Operating Income (Loss) $429.0m $425.8m $541.8m $579.3m $809.7m $903.7m $1.0b $1.1b $1.3b $1.7b
Additional Financial Items
Amortization of Intangible Assets $30.2m $46.6m $46.4m $74.9m $49.6m $45.1m $39.6m $30.4m $33.0m $32.1m
Debt and Equity Securities, Unrealized Gain (Loss) ($4.0m) ($10.3m)
Equity Securities, FV-NI, Realized Gain (Loss) $4.0m $3.9m $389k
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount $14.5m ($14.5m) $12.2m ($9.9m)
Foreign Currency Transaction Gain (Loss), before Tax $4.2m $5.4m ($1.5m) $1.7m $1.3m ($753k)
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Domestic $1.8m ($5.0m) $42.6m ($34.5m) $60.5m $71.9m ($85.9m) $128.6m $181.1m $359.7m
Income (Loss) from Equity Method Investments ($15.8m) ($25.1m) ($11.2m) ($8.5m) ($7.3m) ($1.8m) $3.6m
Operating Lease, Lease Income $87.9m $93.4m $90.1m
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $439.6m $418.7m $521.3m $518.8m $733.1m $883.7m $960.5m $1.1b $1.3b $1.7b
Net Income (Loss) Attributable to Parent $352.4m $342.3m $315.6m $404.6m $621.7m $474.5m $779.4m $897.6m $1.0b $1.4b
Earnings Per Share, Basic $2.51 $2.42 $2.21 $2.83 $4.31 $3.27 $5.34 $6.12 $6.94 $9.55
Earnings Per Share, Diluted $2.49 $2.40 $2.19 $2.80 $4.27 $3.24 $5.30 $6.09 $6.92 $9.51
Common Stock, Dividends, Per Share, Declared $1.20 $1.32 $1.40 $1.48 $1.56 $1.56 $1.68 $1.76 $1.92 $2.12
Weighted Average Number of Shares Outstanding, Basic 140.2m 141.4m 142.8m 143.1m 144.3m 145.3m 146.1m 146.8m 147.0m 146.7m
Weighted Average Number of Shares Outstanding, Diluted 141.7m 142.5m 144.0m 144.5m 145.7m 146.5m 147.0m 147.5m 147.6m 147.3m
Research and Development Expense $118.7m $144.5m $155.1m $180.7m $201.9m $225.3m $253.6m $287.6m $307.5m $331.3m
Selling, General and Administrative Expense $488.1m $554.0m $600.4m $645.0m $676.7m $670.4m $739.4m $874.0m $917.1m $991.0m
Other Nonoperating Income (Expense) $5.0m $4.1m ($8.5m) ($10.7m) ($12.2m) $14.8m $3.2m ($5.7m) ($3.5m) ($5.3m)
Business Combination, Acquisition Related Costs $5.3m $10.1m $6.1m $0 $0 $10.9m $0 $2.0m
Current Income Tax Expense (Benefit) $88.2m $80.9m $198.8m $163.8m $141.3m $425.7m $192.9m $249.5m $293.7m $337.8m
Interest Expense $11.2m $28.2m $28.4m $36.2m $40.4m $24.0m
Restructuring Costs $0
Income Tax Expense (Benefit) $87.2m $76.5m $205.7m $114.3m $111.4m $409.2m $181.0m $204.1m $243.8m $276.8m
Interest Income (Expense), Net ($22.3m) ($47.4m)
Interest Income (Expense), Nonoperating, Net ($45.7m) $4.1m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.